Entourage Health Corp. ENTG ETRGF (FSE:4WE) has entered into an exclusive licensing, manufacturing and distribution agreement with Irwin Naturals Inc. IWINF IWIN (FRA:97X). The new line of CBD and THC products to be produced under the agreement, curated by Entourage alongside Irwin’s wholly owned subsidiary Irwin Naturals Cannabis, are expected to launch first on Entourage’s Starseed Medicinal channel in Q4, 2022, with eventual expansion into retail markets across Canada.
Under the terms of the agreement, Entourage will manufacture the newly formulated suite of Irwin-branded line of softgels in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid. In light of recent recommendations issued by Health Canada’s Science Advisory Committee on Health Products Containing Cannabis, the Irwin-branded CBD products could eventually launch over-the-counter in pharmacies across Canada.
Expanded Medical Services
Entourage is fully committed to expanding its medical product portfolio as the company looks to provide greater service and products to its patient base – which has grown over 50% since merging the Starseed Medicinal brand under the Entourage family in late 2019. The company has expanded partnerships with unions, employers, insurers and benefit providers which has seen a surge in patient registrations over recent months.
Starseed’s direct-to-patient medical marketplace currently offers over 45 products, including cannabis-infused soft chews, transdermal patches, compounds (balms), oils, capsules, vapes, and dried flower products, including a new high-THC cultivar reserve (15g). The company recently entered into partnership with HelloMD, a leading online telehealth network to provide expanded access to cannabis-trained medical practitioners and Pineapple Express to provide same-day/next day delivery as an additional convenience to patients residing within select areas in Ontario.
Photo: Benzinga; Sources: courtesy of geralt, lindsayfox via Pixabay
Related News
Entourage Expands Medical Cannabis Offerings With Launch Of New Services And Products
Entourage Health Amends Its Credit Facilities To Improve Debt Position
Irwin Naturals Acquires Third Ketamine Clinic, Steps Further Into New England Region
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!